SCHEMBL30591849

SCHEMBL30591849

C=CC(=O)N1CCN(c2nccnc2Nc2cnc(C(F)(F)F)nc2)CC1

nearest known ligand 0.39

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 3/20 0.39
▸ GAA P10253 1/20 0.37
▸ JAK3 P52333 1/20 0.37
▸ EGFR P00533 4/20 0.37
▸ BTK Q06187 1/20 0.37
▸ F13A1 P00488 1/20 0.37
▸ TGM2 P21980 1/20 0.37
▸ TGM1 P22735 1/20 0.37
▸ KRAS P01116 4/20 0.36
▸ HRH3 Q9Y5N1 1/20 0.36
▸ HSD11B1 P28845 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26108175 0.84 TRPV1 (0.53) TRPV1EGFR
SCHEMBL30591667 0.84 TRPV1 (0.53) TRPV1EGFR
SCHEMBL30591835 0.84 EGFR (0.38) TRPV1GAAJAK3EGFRBTK
SCHEMBL30591862 0.83 EGFR (0.43) TRPV1GAAJAK3EGFRBTK
SCHEMBL26107144 0.83 EGFR (0.43) TRPV1GAAJAK3EGFRBTK
SCHEMBL26107420 0.82 TRPV1 (0.41) TRPV1GAAJAK3EGFRBTK
SCHEMBL30591804 0.82 TRPV1 (0.41) TRPV1GAAJAK3EGFRBTK
SCHEMBL26108669 0.81 EGFR (0.42) TRPV1EGFRBTKKRAS
SCHEMBL30591759 0.81 EGFR (0.42) TRPV1EGFRBTKKRAS
SCHEMBL30591906 0.81 TRPV1 (0.49) TRPV1EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250206722-A1 SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS THE SCRIPPS RESEARCH INSTITUTE 2025-06-26 — — US claimed
CN-119403551-A Small molecule inhibitors of TEA domain family members 斯克里普斯研究学院 2025-02-07 — — CN claimed
EP-4496570-A2 SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS The Scripps Research Institute (US) 2025-01-29 — — EP claimed
WO-2023183768-A2 SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS THE SCRIPPS RESEARCH INSTITUTE (US) 2023-09-28 — — WO claimed
US-20250206722-A1 SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS THE SCRIPPS RESEARCH INSTITUTE 2025-06-26 — — US disclosed
CN-119403551-A Small molecule inhibitors of TEA domain family members 斯克里普斯研究学院 2025-02-07 — — CN disclosed
EP-4496570-A2 SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS The Scripps Research Institute (US) 2025-01-29 — — EP disclosed
WO-2023183768-A2 SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS THE SCRIPPS RESEARCH INSTITUTE (US) 2023-09-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250206722-A1 SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS YAP1, TEAD1, TEAD2 TRPV1 3566/4885GAA 4142/4885JAK3 2267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback